Dermoscribe

Dermoscribe is a specialized pharmaceutical company focused on the development and distribution of dermatological treatments for common and chronic skin conditions. Founded by experienced dermatologists, the company provides evidence-based topical formulations for indications such as seborrheic dermatitis, psoriasis, and chronic pruritus. Their product portfolio includes specialized creams and shampoos that utilize established active ingredients in optimized concentrations to provide relief where standard over-the-counter options may be insufficient. Dermoscribe's flagship Seborrheic Dermatitis Cream is widely recognized for its efficacy in managing facial and scalp redness and scaling. The company operates an international business model, primarily reaching patients through e-commerce platforms in the United States, Australia, and other global markets. By focusing on proven clinical ingredients, Dermoscribe aims to offer professional-grade dermatological solutions directly to consumers.